Glioblastoma (Record no. 110197)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03479nam a22004455i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-4419-0410-2 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220084502.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 100301s2010 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781441904102 |
| -- | 978-1-4419-0410-2 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-4419-0410-2 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC261-271 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJCL |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED062000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 614.5999 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ray, Swapan K. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Glioblastoma |
| Medium | [electronic resource] : |
| Remainder of title | Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies / |
| Statement of responsibility, etc | edited by Swapan K. Ray. |
| 264 #1 - | |
| -- | New York, NY : |
| -- | Springer New York, |
| -- | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XII, 431p. 49 illus., 18 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Overview of the Molecular Genetics and Molecular Chemotherapy of GBM -- Primary Brain Tumors: Characteristics, Practical Diagnostic and Treatment Approaches -- Pathology of Glioblastoma Multiforme -- Molecular Mechanisms of Pathogenesis in Glioblastoma and Current Therapeutic Strategies -- Aberrant Signalling Complexes in GBMs: Prognostic and Therapeutic Implications -- Role of Aberrant Cell Cycle in the Growth and Pathogenesis of Glioblastoma -- Adult Neural Stem Cells and Gliomagenesis -- Divide and Invade: The Dynamic Cytoskeleton of Glioblastoma Cells -- Aberrations of the Epigenome in Gliomas: Novel Targets for Therapy -- Chemotherapy for Glioblastoma: Past, Present, and Future -- Role of Angiogenesis in the Pathogenesis of Glioblastoma and Antiangiogenic Therapies for Controlling Glioblastoma -- Antiangiogenic Strategies for the Treatment of Gliomas -- Retinoids for the Treatment of Glioblastoma -- Molecular Mechanisms of Taxol for Induction of Cell Death in Glioblastomas -- Current Endeavors for Enhancing Efficacy of Paclitaxel for Treatment of Glioblastoma -- Dietary Polyphenols as Preventive and Therapeutic Agents in Glioblastoma -- Targeting Energy Metabolism in Brain Cancer with Restricted Diets -- Immunotherapy for Glioblastoma -- Potential of Nanobiotechnology in the Management of Glioblastoma Multiforme. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Glioblastoma, the deadliest of all primary brain tumors, is heterogenic and has very complex pathology and multiple mechanisms of cell proliferation and growth. This book describes all the latest concepts about the molecular mechanisms of pathogenesis of glioblastoma and new therapeutic opportunities. The contributors to this book include basic scientists and clinicians, who are experts in the field, and dedicated investigators in finding novel strategies for treatment of glioblastoma. It is important for us to know the strategies we have accumulated so far for the management of this malignancy so that we can make further attempts to explore unknown avenues to combat it completely in the near future. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurosciences. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Research. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurosciences. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781441904096 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-4419-0410-2 |
| 912 ## - | |
| -- | ZDB-2-SBL |
No items available.